Impact of Intensive Therapy for Diabetes: Summary of Major Clinical Trials - What is Type 2 Diabetes? - Harms - Current Challenges of Type 2 Diabetes Mellitus
![Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | SpringerLink Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-020-05224-2/MediaObjects/125_2020_5224_Figa_HTML.png)
Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | SpringerLink
![A Leading Diabetes Drugs Manufacturer Understood the Effectiveness of Clinical Trials against Real-World Data | Quantzig | Business Wire A Leading Diabetes Drugs Manufacturer Understood the Effectiveness of Clinical Trials against Real-World Data | Quantzig | Business Wire](https://mms.businesswire.com/media/20180614005553/en/663435/5/Patient_Journey_Analysis_for_a_Diabetes_Drugs_Manufacturer_Helps_Comprehend_the_Effectiveness_of_Clinical_Trials_Against_Real_World_Data.jpg)
A Leading Diabetes Drugs Manufacturer Understood the Effectiveness of Clinical Trials against Real-World Data | Quantzig | Business Wire
![Clinical Trial for Novel Investigational Treatment of Type 1 Diabetes Open for Enrollment in Miami - World Stem Cell Summit Clinical Trial for Novel Investigational Treatment of Type 1 Diabetes Open for Enrollment in Miami - World Stem Cell Summit](https://www.regmedfoundation.org/wp-content/uploads/2021/04/2021-04-08_press-release-dri-university-of-miami-vertex.jpg)
Clinical Trial for Novel Investigational Treatment of Type 1 Diabetes Open for Enrollment in Miami - World Stem Cell Summit
![Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/e2a21372-5bd4-44a4-ae0e-088bddb9db3b/gr1.jpg)
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology
![Registry-based randomised clinical trials: a remedy for evidence-based diabetes care? | SpringerLink Registry-based randomised clinical trials: a remedy for evidence-based diabetes care? | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-022-05762-x/MediaObjects/125_2022_5762_Figa_HTML.png)